Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE

Champoux Jennifer sold 2,176 Monte Rosa Therapeutics, Inc. shares (Form 4)

Traded Jun 17, 2026 · Filed Jun 18, 2026

On Jun 17, 2026, Champoux Jennifer (Chief Operating Officer) sold 2,176 Monte Rosa Therapeutics, Inc. shares at US$19.00 for US$41,344 under a trading plan, leaving 62,371 shares. Filed Jun 18, 2026 (Form 4).

Sold
2,176 shares
Price
US$19.00
Value
US$41,344
Holding after
62,371 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 17, 2026Common StockOption exercise2,176US$3.9864,547Direct
Jun 17, 2026Common StockSale2,176US$19.0062,371Direct

Source

View original at SEC

Related